<DOC>
	<DOCNO>NCT02312414</DOCNO>
	<brief_summary>Anemia common disorder CKD patient . It largely attribute decreased erythropoietin ( EPO ) production iron deficiency . Therefore , besides EPO , therapy include iron replenishment . However , latter induces oxidative stress . Haptoglobin ( Hp ) protein main line defense oxidative effect Hemoglobin/Iron . There 3 genotype : 1-1 , 2-1 2-2 . Hp 2-2 protein inferior Hp 1-1 antioxidant . So far , evidence whether haptoglobin genotype affect iron-induced oxidative stress CKD patient . In propose study wish examine whether Hp genotype influence intravenous iron administration ( IVIR ) -induced oxidative stress CKD patient , impact response patient L-Carnitine therapy .</brief_summary>
	<brief_title>Effects Carnitine Oxidative Stress IVIR Administration CKD Patients : Impact Haptoglobin Genotype</brief_title>
	<detailed_description>This study include least 25 anemic CKD patient ( stage 3-4 ) give weekly IVIR ( Sodium ferric gluconate , [ 125 mg/100 ml ] 8 week , week 5-8 also receive Carnitine ( 20mg/kg , IV ) prior IVIR . Weekly blood sample draw IVIR Hp genotype , C-reactive protein ( CRP ) , advance oxidative protein product ( AOPP ) , neutrophil gelatinase-associated lipocalin ( NGAL ) , besides complete blood count biochemical analysis .</detailed_description>
	<mesh_term>Ferric gluconate</mesh_term>
	<criteria>1 . Patients diagnose suffer chronic kidney disease stag 34 confirmed MDRD . 2 . CKD patient Hb le 10 g % . 3 . At age â‰¥18 . 1 . Pregnant woman . 2 . Patient CKD stage 5 Dialysis . 3 . Patients severe liver disease . 4 . Patients severe CHF . 5 . Intercurrent illness fever . 6 . Allergic rhinitis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>